Envision Healthcare (EVHC) Misses Q2 EPS by 2c, FY EPS Guidance Comes in Light

Envision Healthcare (NYSE: EVHC) reported Q2 EPS of $0.34, $0.02 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $1.64 billion versus the consensus estimate of $1.66 billion.

GUIDANCE:

Envision Healthcare sees FY2016 EPS of $1.42-$1.47, versus the consensus of $1.49.

• Adjusted EBITDA of $715 million to $730 million

For earnings history and earnings-related data on Envision Healthcare (EVHC) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance